A phase 2 study of pembrolizumab (MK-3475) after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma Meeting Abstract
| Authors: | Merrill, M. H.; Dahi, P. B.; Redd, R. A.; McDonough, M. M.; Chen, Y. B.; LaCasce, A. S.; Fisher, D. C.; Herrera, A. F.; Jacobson, C. A.; Kim, A. I.; Merryman, R. W.; Odejide, O. O.; Ng, S.; Nieto, Y.; Sauter, C. S.; Shah, G. L.; Zain, J.; Armand, P.; Jacobsen, E. D. |
| Abstract Title: | A phase 2 study of pembrolizumab (MK-3475) after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1185 |
| End Page: | 1187 |
| Language: | English |
| ACCESSION: | WOS:000893223201076 |
| DOI: | 10.1182/blood-2022-164839 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work